Dr. Huajie Jin (Lily) is a Senior Lecturer in Health Economics at King’s College London (KCL). She also holds an Honorary Associate Professorship at University College London (UCL), and at the Health Technology Assessment Research Department of the Shanghai Health Development Research Centre. In her role as Deputy Head at the King's Health Economics, she is responsible for managing and supporting research funding applications and staffing issues. Since June 2021, Dr. Jin has been the sole health economic advisor to the scrutiny panel for planned care, reporting to the Welsh government.

Before joining KCL, she worked on the National Institute for Health and Care Excellence (NICE) clinical guidelines for three years. During this period, Lily was the principal health economist of three NICE clinical guidelines and three NICE Medtech innovation briefings (MIBs).

Dr. Jin leads health economic analysis for several large-scale clinical trials and assists NICE in cost assessments of advanced medical technologies. In the past few years, she has collaborated with multiple clinical teams in the United Kingdom, the Netherlands, and Africa, winning several research grants funded by the National Institute for Health Research (NIHR), the Royal Society of the United Kingdom, and the European Union's "Horizon Europe" program.

Her primary research focuses on health economic evaluation, cost-of-illness studies, and whole disease modeling. The health technologies she has evaluated or is currently evaluating include:

· Cancer: Breast cancer screening, cervical cancer screening, precision medicine for liver cancer, diagnostic techniques for cerebral aneurysms, and preventive measures for neutropenic sepsis.

· Mental and psychological disorders: Antipsychotic drugs, cognitive-behavioural therapy, precision medicine for schizophrenia, screening for prenatal depression, and antidepressant drugs.

· Chronic diseases: Self-management support for diabetes patients and drug treatments for chronic obstructive pulmonary disease.

· Acute diseases: Ventilation assistance systems in intensive care units, intervention time for acute renal failure, and blood perfusion in end-stage kidney disease.

· Infectious diseases: Tuberculosis screening and optimal lockdown time during the spread of novel coronavirus pneumonia.

· Others: Orthodontics.

Dr. Jin has published research findings in several high-impact academic journals, including Lancet Psychiatry, Bulletin of the World Health Organization, JAMA Network Open, and the British Journal of Psychiatry. She also serves as a reviewer for several journals, including The Lancet Global Health, The Lancet Public Health, The Lancet Infectious Disease, Value in Health, and PharmacoEconomics.

Currently, Dr. Jin is the primary supervisor for four PhD students at King's College London and serves as the secondary supervisor for a PhD student at University College London.